Study of disease processes in children getting liver transplants
Part of Digestive system, Genetic & congenital clinical trials.
This study maps how biliary atresia (a childhood blockage/problem with bile flow from the liver) progresses and changes in the body around the time of a liver transplant. It may help doctors better understand the disease and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your child) have been diagnosed with biliary atresia.
- You received a liver transplant already, or are about to receive one.
- The transplant must be through one of the study’s participating centers (including Children’s Hospital of Pittsburgh, Kings College Hospital, Children’s Hospital of Birmingham, or Hospital Sírio-Libanês).
- You must be a living patient (not a deceased case).
- You should not be enrolled if the child is in state care or under a temporary or informal guardian.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study enrolls children and young adults with biliary atresia (a condition where bile can’t flow properly from the liver) to learn from their care and outcomes over scheduled visits. It may help researchers understand the disease better and improve future treatment.
This study follows babies under 6 months old who have early signs of liver disease (cholestasis) to better understand what causes it and how it progresses. Researchers will collect medical information over time to improve diagnosis and treatment.
This study looks to better understand biliary atresia by studying patient information and/or samples. It may help researchers learn why the condition happens and how to improve care.
This trial is studying children who have biliary atresia, a serious liver problem, including some who also have tetralogy of Fallot (a congenital heart condition). It also includes healthy children for comparison, and may help researchers understand the illness and treatments better.
This study is testing whether stem cells can help infants with liver cirrhosis from biliary atresia (a blocked bile duct condition) who have already had Kasai surgery. It aims to see if stem cell therapy can improve liver function and reduce complications.
This study looks at why childhood liver tumors happen by using samples and information from children who have had a liver tumor and from their close family members. It may help researchers understand the biology of these tumors and guide better treatments in the future.
Hear when a new Biliary Atresia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.